Astrana Health, Inc.: 10-Q filed 2017-02-14

Name: Astrana Health, Inc.: 10-Q filed 2017-02-14
Creator: Astrana Health, Inc.

What Astrana Health, Inc. reported in its quarterly report filed 2017-02-14 (fiscal Q3 2017): 31 published measures, 85 facts as tagged in accession 0001144204-17-009037.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-02-14
Fiscal period: fiscal Q3 2017
Accession: 0001144204-17-009037 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Astrana Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-12-31	16,784,560	USD
At 2016-03-31	19,566,533	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-12-31	11,086,950	USD
At 2016-03-31	11,015,247	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-12-31	3,786,318	USD
At 2016-03-31	-1,269,427	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-12-31	3,988,565	USD
At 2016-03-31	9,270,010	USD
At 2015-12-31	4,644,722	USD
At 2015-03-31	5,014,242	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-1,732,706	USD	92
2016-04-01 to 2016-12-31	-4,406,372	USD	275
2015-10-01 to 2015-12-31	-1,685,611	USD	92
2015-04-01 to 2015-12-31	-4,699,344	USD	275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-04-01 to 2016-12-31	259,551	USD	275
2015-04-01 to 2015-12-31	165,980	USD	275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	15,674,876	USD	92
2016-04-01 to 2016-12-31	42,669,205	USD	275
2015-10-01 to 2015-12-31	10,659,708	USD	92
2015-04-01 to 2015-12-31	32,233,441	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-12-31	-33,090,937	USD
At 2016-03-31	-28,684,565	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	99,516	USD	92
2016-04-01 to 2016-12-31	-127,077	USD	275
2015-10-01 to 2015-12-31	36,196	USD	92
2015-04-01 to 2015-12-31	-57,251	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-12-31	1,301,914	USD
At 2016-03-31	1,247,973	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-1,675,854	USD	92
2016-04-01 to 2016-12-31	-5,612,730	USD	275
2015-10-01 to 2015-12-31	-1,459,472	USD	92
2015-04-01 to 2015-12-31	-3,537,077	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-12-31	10,805,439	USD
At 2016-03-31	13,558,497	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	9,993	USD	92
2016-04-01 to 2016-12-31	15,706	USD	275
2015-10-01 to 2015-12-31	100,983	USD	92
2015-04-01 to 2015-12-31	530,203	USD	275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-12-31	10,229,123	USD
At 2016-03-31	7,431,780	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2016-12-31	1,622,483	USD
At 2016-03-31	1,622,483	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2016-12-31	1,365,000	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-12-31	5,985,903	USD
At 2016-03-31	3,392,941	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	17,350,730	USD	92
2016-04-01 to 2016-12-31	48,281,935	USD	275
2015-10-01 to 2015-12-31	12,119,180	USD	92
2015-04-01 to 2015-12-31	35,770,518	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-12-31	6,033,518	shares
At 2016-03-31	5,876,852	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-12-31	25,908,699	USD
At 2016-03-31	23,524,517	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2016-12-31	5,697,610	USD
At 2016-03-31	1,473,508	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2016-12-31	2,067,737	USD
At 2016-03-31	2,353,212	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-12-31	221,987	USD
At 2016-03-31	216,442	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-12-31	499,150	USD
At 2016-03-31	293,828	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-1,484,475	USD	92
2016-04-01 to 2016-12-31	-3,854,607	USD	275
2015-10-01 to 2015-12-31	-1,532,963	USD	92
2015-04-01 to 2015-12-31	-4,057,294	USD	275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	4,485,932	USD	92
2016-04-01 to 2016-12-31	12,777,736	USD	275
2015-10-01 to 2015-12-31	3,510,045	USD	92
2015-04-01 to 2015-12-31	11,187,891	USD	275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	148,934	USD	92
2016-04-01 to 2016-12-31	484,147	USD	275
2015-10-01 to 2015-12-31	145,594	USD	92
2015-04-01 to 2015-12-31	287,029	USD	275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	888	USD	92
2016-04-01 to 2016-12-31	13,419	USD	275
2015-10-01 to 2015-12-31	-100,344	USD	92
2015-04-01 to 2015-12-31	-94,431	USD	275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	290,895	USD	92
2016-04-01 to 2016-12-31	1,631,046	USD	275
2015-10-01 to 2015-12-31	-37,295	USD	92
2015-04-01 to 2015-12-31	-577,468	USD	275

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2016-04-01 to 2016-12-31	0	USD	275
2015-04-01 to 2015-12-31	9,193	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-04-01 to 2016-12-31	2,753,595	USD	275
2015-04-01 to 2015-12-31	49,119	USD	275

Inspect the source

Entity: Astrana Health, Inc. / CIK 0001083446
Captured: 2026-09-20T05:20:50.832Z
SEC response SHA-256: 24589a8b90ad6a7cdaab8fd1b252b61b042f4e45ec87312920857f7a3d1d7dfe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001083446.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))